Alliance A222001: A Randomized, Double-Blind, Placebo Controlled Phase II Study of Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Men Receiving Androgen Deprivation Therapy
- Citation:
- J Clin Oncol vol 24 (16_suppl) LBA12004
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Disparities
- Pharmas:
- Grants:
- UG1CA189823
- Corr. Author:
- Authors:
- Brad J. Stish Gina L. Mazza Jones T. Nauseef Michael Sandon Humeniuk Thomas J. Smith Cindy Tofthagen Dayssy Alexandra Diaz Pardo Christopher Chay Andrew Huang Kushal Naha Scott T. Tagawa Selina Chow Lucile L. Adams-Campbell Paul J. Novotny Charles L. Loprinzi
- Networks:
- CAPITAL, CROWN, LAPS-MD017, LAPS-MN026, MO036, NY018, SCOR, UPSTATE
- Study
- Alliance-A222001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: